Allergy & Immunology Doctors in Mount Pleasant, SC Accepting Medicare

3 Allergy & Immunology doctors found. Showing 1 - 3

Elizabeth Irene Majeski, MD Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 180 Wingo Way Ste 102, Mount Pleasant, SC 29464 Phone: 843-881-2030    Fax: 843-881-6249

Dr. Marvin M Portner, M.D. Allergy & Immunology - Allergy Medicare: Not Enrolled in Medicare Practice Location: 1783 Shell Ring Cir, Mount Pleasant, SC 29466 Phone: 310-266-3050    Fax: 310-454-5318

Dr. Victoria M Diokno, M.D. Allergy & Immunology Medicare: Not Enrolled in Medicare Practice Location: 100 Fair Sailing Rd, Mount Pleasant, SC 29466 Phone: 843-276-2630

News Archive

Depressed smokers may benefit from mood management interventions

Studies have shown that people with depression are about twice as likely to smoke cigarettes as people without depression and they are less likely to successfully quit than smokers without depression.

Researchers examine perceptions, experiences of professionalism in health care institutions

Marginalized groups of people value professionalism more - and are more likely to leave a job at an institution due to issues of professionalism - compared to their white, male counterparts, according to a Penn Medicine study of staff, faculty, and students who were affiliated with a large, academic health system in 2015 and 2017.

Two distinct brain regions involve in decision-making process, research shows

Often when we make a decision, we calculate its "expected value," by multiplying the value of something (how much we want or need it) with the probability that we might be able to obtain it, a concept first introduced by 17th-century mathematician Blaise Pascal.

QRxPharma reports positive outcome of European Scientific Advice meetings on MoxDuo IR pain therapy

QRxPharmareported today positive outcomes of its European Scientific Advice meetings on the development and registration of MoxDuo IR, an immediate release Dual-Opioid™ pain therapy. The Company is currently completing pivotal Phase 3 trials required for filing a New Drug Application (NDA) for MoxDuo IR with the United States Food and Drug Administration (FDA).

Read more Medical News

› Verified 5 days ago